SIM
BIOC

Spark Investment Management’s Biocept, Inc. BIOC Stock Holding History

Spark Investment Management’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8
Closed -$492K – 754
2015
Q1 		$492K Buy
+8
New +$537K 0.07% 369

Other funds holding BIOC

KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $223M AUM 17.15% 1-Year Est. Return

Spark Investment Management's BIOC Position: Q2 2015 in Review

Spark Investment Management sold out of Biocept, Inc. (BIOC) in Q2 2015, closing a stake of 8 shares — an estimated $492K sold.

Spark Investment Management first reported a position in BIOC in Q1 2015 and held it in 1 quarter. The position peaked at $492K in Q1 2015. 12 funds tracked by Wall St. Rank hold BIOC as of Q2 2015.

  • Spark Investment Management reported no remaining Biocept, Inc. position as of Q2 2015 after selling out during the quarter.
  • Spark Investment Management sold 8 Biocept, Inc. shares in Q2 2015, an estimated $492K.
  • Spark Investment Management first reported a position in Biocept, Inc. in Q1 2015 and held it in 1 quarter.
  • Spark Investment Management's Biocept, Inc. position peaked at $492K in Q1 2015.
  • 12 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2015.

Based on Spark Investment Management's 13F filing for Q2 2015, filed 12 Aug 2015.